Outcomes of the Intradural Extramedullary Tumors Resection

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05023772` - Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases	N/A
Not yet recruiting	`NCT06357377` - A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors	Phase 1
Completed	`NCT00430872` - Development of the MDASI-Spine Tumor Module	N/A
Recruiting	`NCT05678608` - Surgical Outcome of Dorsolumbar Intradural Extramedullary Spinal Cord Tumors	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05023772 - Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases

N/A

Not yet recruiting

NCT06357377 - A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

Phase 1

Completed

NCT00430872 - Development of the MDASI-Spine Tumor Module

N/A

Recruiting

NCT05678608 - Surgical Outcome of Dorsolumbar Intradural Extramedullary Spinal Cord Tumors

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04331431
Study type	Interventional
Source	Sohag University
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2008
Completion date	April 8, 2015

Outcomes of the Intradural Extramedullary Tumors Resection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms